The Uromigos Episode 166: Prostate Cancer Debate—Doublet Versus Triplet First-Line Therapy

The Uromigos moderate this intriguing prostate cancer treatment debate featuring Drs. Rana McKay and Kim Chi, who discuss two recently published trials and question whether doublet or triplet therapy is appropriate in the first-line.